Clinical trials advances for better health outcomes

NHMRC临床试验中心（CTC）旨在利用临床试验和试验方法研究来改善澳大利亚和国际上的健康。其研究计划将启动重大的新的临床试验和一个全面的研究计划，包括试验方法，生物统计分析，健康结果分析和决策分析。患者的偏好和决策，特别是癌症患者的偏好和决策，将成为关注的焦点。CTC在综合分析中使用自己和其他临床试验的数据，以获得更好的证据。NHMRC计划拨款将允许重要的研究与行业和其他来源资助的试验相结合，并将保持CTC的国际竞争力的研究团队处于新试验方法和系统的最前沿。

The NHMRC Clinical Trials Centre (CTC) aims to use clinical trials and methodological research in trials to improve health in Australia and internationally. Its research program will initiate major new clinical trials and a comprehensive program of research into trial methods, biostatistical analysis, health outcome analysis and decision analysis. Patient preferences and decision making, particularly in cancer, will be a focus. CTC uses data from its own and other clinical trials in combined analyses to arrive at better evidence. The NHMRC program grant will allow important research studies to be integrated with trials funded from industry and other sources and will maintain the CTC’s internationally competitive research team at the cutting edge of new trial methods and systems.